Join
Live feed
·
INSIDERFilingvia Quantisnow
Nasus Pharma Ltd. logo

SEC Form 4 filed by Chief Executive Officer Teleman Dan Benjamin

ByQuantisnow·Wall Street's wire, on your screen.
NSRX· Nasus Pharma Ltd.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NSRX (Nasus Pharma Ltd.) and more on Quantisnow.

SEC Form 4 filed by Chief Executive Officer Teleman Dan Benjamin | Quantisnow